Management of Patients with Type 2 Diabetes by Pharmacists in Primary Care Clinics

Abstract

Spanish

French

OBJECTIVE:

To determine the impact of clinical pharmacists involved in direct patient care on the glycemic control of patients with type 2 diabetes mellitus.

DESIGN:

Eligible patients included those with type 2 diabetes who received insulin or were initiated on insulin therapy by the pharmacists and were willing to perform self-monitoring of blood glucose. The pharmacists provided diabetes education, medication counseling, monitoring, and insulin initiation and/or adjustments. All initial patient interactions with the pharmacists were face-to-face. Thereafter, patient–pharmacist interactions were either face-to-face or telephone contacts.

SETTING:

Two primary care clinics in a university-affiliated Veterans Affairs Medical Center.

PARTICIPANTS:

Study subjects were patients with type 2 diabetes who were referred to the pharmacists by their primary care providers for better glycemic control.

OUTCOME MEASURES:

Primary outcome variables were changes from baseline in glycosylated hemoglobin, fasting blood glucose, and random blood glucose measurements. Secondary outcomes were the number and severity of symptomatic episodes of hypoglycemia, and the number of emergency room visits or hospitalizations related to diabetes. Twenty-three veterans aged 65 ± 9.4 years completed the study. Fifteen (65%) patients were initiated on insulin by the pharmacists; 8 (35%) were already using insulin. Patients were followed for a mean ± SD of 27 ± 10 weeks. Glycosylated hemoglobin, fasting blood glucose concentrations, and random blood glucose concentrations significantly decreased from baseline by 2.2% (p = 0.00004), 65 mg/dL (p < 0.01), and 82 mg/dL (p = 0.00001), respectively. Symptomatic hypoglycemic episodes occurred in 35% of patients. None of these episodes required physician intervention.

CONCLUSIONS:

This study demonstrates that pharmacists working as members of interdisciplinary primary care teams can positively impact glycemic control in patients with type 2 diabetes requiring insulin.

Keywords

type 2 diabetes primary care pharmacists

Get full access to this article

View all access options for this article.

References

American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1997;20(suppl 1):S5–13.

McDaniel

Gay

. Diabetes self-care knowledge, behaviors, and metabolic control of older adults — The effect of a posteducational follow-up program. Diabetes Educ 1993;19:25–30.

Shaffer

Wexler

. Reducing low-density lipoprotein cholesterol levels in an ambulatory care system: Results of a mutidisciplinary collaborative practice lipid clinic compared with traditional physician-based care. Arch Intern Med 1995;155:2330–5.

Pauley

Magee

Cury

. Pharmacist-managed, physician-directed asthma management program reduces emergency department visits. Ann Pharmacother 1995;29:5–9.

McKenney

Witherspoon

. The impact of outpatient hospital pharmacists on patients receiving antihypertensive and anticoagulant therapy. Hosp Pharm 1985;20:406,409–11,415.

Patchin

Wieland

Carmichael

. Six months' experience with a pharmacist-run Helicobacter pylori treatment clinic. Am J Health-Syst Pharm 1996;53:2081–2.

Rosen

Holmes

. Pharmacist's impact on chronic psychiatric outpatients in community mental health. Am J Hosp Pharm 1978;35:704–8.

Dorevitch

Aronzon

Zilberman

. Medication maintenance of chronic schizophrenic out-patients by a psychiatric clinical pharmacist: 10 year follow-up study. J Clin Pharm Ther 1993;18:183–6.

Radley

Hall

Farrow

Carey

. Evaluation of anticoagulant control in a pharmacist-operated anticoagulant clinic. J Clin Pathol 1995;48:545–7.

10.

Conte

Kehoe

Nielson

Lodhia

. Nine-year experience with a pharmacist-managed anticoagulation clinic. Am J Hosp Pharm 1986;43:2460–4.

11.

Garabedian-Ruffalo

Gray

Sax

Ruffalo

. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm 1985;42:304–8.

12.

Jaber

Halapy

Fernet

Tummalapalli

Diwakaran

. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996;30:238–43.

13.

van Veldhuizen-Scott

Widmer

Stacey

Popovich

. Developing and implementing a pharmaceutical care model in an ambulatory care setting for patients with diabetes. Diabetes Educ 1995;21:117–23.

14.

Tiggelaar

. Protocols for the treatment of essential hypertension and type II diabetes mellitus by pharmacists in ambulatory care clinics. Drug Intell Clin Pharm 1987;21:521–9.

15.

Huff

Ives

Almond

Griffin

. Pharmacist-managed diabetes education services. Am J Hosp Pharm 1983;40:991–4.

16.

Hawkins

Fieldler

Douglas

Eschbach

. Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm 1979;36:1321–5.

17.

Schilling

. Pharmacy program for monitoring diabetic patients. Am J Hosp Pharm 1977;34:1242–5.

18.

Sczupak

Conrad

. Relationship between patient-oriented pharmaceutical services and therapeutic outcomes of ambulatory patients with diabetes mellitus. Am J Hosp Pharm 1977;34:1238–42.

19.

Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–86.

20.

Abraira

Colwell

Nuttall

Sawin

Nagel

N Johnson

Comstock

Veterans Affairs cooperative study on glycemic control and complications in type II diabetes (VA CSDM). Diabetes Care 1995;18:1113–23.

21.

Rubin

Altman

Mendelson

. Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 1994;78:809A–F.

22.

Veterans Health Administration, Medical Information Resources Management Office, Veterans Administration Decentralized Hospital Computer Program, PIMS (MAS), V5.3, User manual (PTF menu), Vol. I. 7–1, August 13, 1993.